182 related articles for article (PubMed ID: 22308243)
1. Critique of apixaban versus warfarin in patients with atrial fibrillation.
Nedeltchev K
Stroke; 2012 Mar; 43(3):922-3. PubMed ID: 22308243
[No Abstract] [Full Text] [Related]
2. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
Garcia DA; Wallentin L; Lopes RD; Thomas L; Alexander JH; Hylek EM; Ansell J; Hanna M; Lanas F; Flaker G; Commerford P; Xavier D; Vinereanu D; Yang H; Granger CB
Am Heart J; 2013 Sep; 166(3):549-58. PubMed ID: 24016506
[TBL] [Abstract][Full Text] [Related]
3. Apixaban for the prevention of stroke in atrial fibrillation.
Littrell R; Flaker G
Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):143-9. PubMed ID: 22292869
[TBL] [Abstract][Full Text] [Related]
4. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
5. [Atrial fibrillation. Apixaban reduces stroke risk].
MMW Fortschr Med; 2013 Mar; 155(4):70-1. PubMed ID: 23614202
[No Abstract] [Full Text] [Related]
6. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
Strain J; Templeton K
S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
[No Abstract] [Full Text] [Related]
7. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Lopes RD; Alexander JH; Al-Khatib SM; Ansell J; Diaz R; Easton JD; Gersh BJ; Granger CB; Hanna M; Horowitz J; Hylek EM; McMurray JJ; Verheugt FW; Wallentin L;
Am Heart J; 2010 Mar; 159(3):331-9. PubMed ID: 20211292
[TBL] [Abstract][Full Text] [Related]
8. Apixaban in patients with atrial fibrillation.
Owen A
N Engl J Med; 2011 Jun; 364(24):2363; author reply 2363-4. PubMed ID: 21675901
[No Abstract] [Full Text] [Related]
9. Apixaban versus warfarin in atrial fibrillation.
Vassiliou VS
N Engl J Med; 2012 Jan; 366(1):88; author reply 89. PubMed ID: 22216849
[No Abstract] [Full Text] [Related]
10. Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis.
Steffel J; Hindricks G
Eur Heart J; 2012 Nov; 33(22):2766-8. PubMed ID: 22933566
[No Abstract] [Full Text] [Related]
11. Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.
Guimarães PO; Lopes RD; Wojdyla DM; Abdul-Rahim AH; Connolly SJ; Flaker GC; Wang J; Hanna M; Granger CB; Wallentin L; Lees KR; Alexander JH; McMurray JJV
Cardiovasc Drugs Ther; 2017 Jun; 31(3):295-301. PubMed ID: 28516318
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
Vinereanu D; Stevens SR; Alexander JH; Al-Khatib SM; Avezum A; Bahit MC; Granger CB; Lopes RD; Halvorsen S; Hanna M; Husted S; Hylek EM; Mărgulescu AD; Wallentin L; Atar D
Eur Heart J; 2015 Dec; 36(46):3268-75. PubMed ID: 26371113
[TBL] [Abstract][Full Text] [Related]
13. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
[TBL] [Abstract][Full Text] [Related]
15. ARISTOTLE expands the list of novel anticoagulants for thromboprophylaxis in atrial fibrillation.
Tzeis S; Andrikopoulos G
Angiology; 2012 Oct; 63(7):558-9. PubMed ID: 22669951
[No Abstract] [Full Text] [Related]
16. [Anticoagulation in atrial fibrillation. Standard in stroke prevention is eliminated].
Overbeck P
MMW Fortschr Med; 2011 Sep; 153(37):12. PubMed ID: 21950180
[No Abstract] [Full Text] [Related]
17. Apixaban in patients with atrial fibrillation.
Lynch DR
N Engl J Med; 2011 Jun; 364(24):2362-3; author reply 2363-4. PubMed ID: 21675902
[No Abstract] [Full Text] [Related]
18. Apixaban (Eliquis)--a new oral anticoagulant for atrial fibrillation.
Med Lett Drugs Ther; 2013 Feb; 55(1409):9-10. PubMed ID: 23381226
[No Abstract] [Full Text] [Related]
19. [The ARISTOTLE study].
Di Pasquale G; De Caterina R
G Ital Cardiol (Rome); 2012 Sep; 13(9):557-62. PubMed ID: 22825340
[No Abstract] [Full Text] [Related]
20. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
Yates SW
Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
